PAA 2.38% 20.5¢ pharmaust limited

Ann: Extension Study Begins, Analysis Suggests Survival Benefit, page-28

  1. 8,819 Posts.
    lightbulb Created with Sketch. 1698
    Thank you NZ, great presentation so now would be a good time to look at survival times on the 5 patients that we have data to work with

    Patient A - total days since diagnosed 808 days or 2.2 years

    Patient B - total days since diagnosed 764 days or 2.09 years

    Patient C - total days since diagnosed 881 days or 2.4 years

    Patient D - total days since diagnosed 1109 or 3 years

    Patient E- total days since diagnosed 2.6 years

    hope they enjoy many more years
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.